eHealth Innovation

What eHealth Innovation does

eHealth Innovation, operating as the Centre for Digital Therapeutics, is a Toronto-based private entity institutionally embedded within Toronto General Hospital, part of University Health Network (UHN) — Canada's largest academic research hospital. The organization develops a portfolio of five distinct digital therapeutic products that transform smartphones and smartwatches into daily monitoring systems for patients living with chronic conditions. Its products include Medly (heart failure management with real-time vitals tracking and clinical flagging), iCanCope with Pain (youth chronic pain self-management), Breathe (asthma and COPD lung health), Ned (cancer survivorship virtual follow-up), and bant (diabetes management). Solutions are co-developed with patient partners possessing lived experience of chronic illness and clinician champions within the hospital system.

The technology stack centers on consumer-grade mobile devices (phones and smartwatches) capturing patient-reported and sensor data, with real-time transmission of vitals and automated flagging of concerning changes to clinical teams for proactive intervention. Each product has a dedicated consumer-facing website alongside clinical-referral distribution within UHN. The organization's value proposition emphasizes engaging and empowering patients to become partners in their own care, with the stated goal of reducing pressure on health systems by enabling earlier intervention before urgent care is needed. Medly received recognition as #7 in Toronto Life's list of twenty homegrown inventions, providing brand visibility.

The business model and revenue mechanics are not publicly disclosed. There is no disclosed pricing, no funding round history, no disclosed commercial customers, and no management team data in the source material. The organization is structured as a research and innovation arm of UHN (a public hospital network) rather than a venture-backed software company, and its distribution is geographically anchored to the Toronto/Ontario healthcare ecosystem. Without disclosed pricing models or commercial transaction data, the primary GTM appears to be institutional embedding within the host hospital, with patient-facing websites serving as supplementary self-serve access channels.

Name

eHealth Innovation

Legal name

Centre for Digital Therapeutics

Website

https://ehealthinnovation.org

Company type

Private

Founded year

2004

Operating status

Operating

Headcount range

11–50 employees

Short description

eHealth Innovation operates the Centre for Digital Therapeutics from inside Toronto General Hospital (UHN), developing a portfolio of five smartphone- and smartwatch-based digital therapeutics that enable patients with chronic conditions — heart failure, chronic pain, asthma/COPD, cancer survivorship, and diabetes — to self-manage their care with real-time monitoring and clinical flagging.

Ownership category

akta.pro rank

Product category

Digital Therapeutics

NAICS

Offices of Physicians (6211)

SIC

Services-Health Services (8000)

akta.pro primary industry

Chronic Disease Management IoT (Diabetes, CHF, COPD, Hypertension) (HLACAPAD)

akta.pro secondary industry

Patient Engagement, Education & Messaging Platforms (portal/CRM integrated) (HLALABAJ)

Keywords

• Digital therapeutics
• Chronic disease management
• Remote patient monitoring
• Mobile health applications
• Healthcare data collection

Headquarters

HQ city

Toronto

HQ country

Canada

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Software

Cost components

Personnel, Technology or R&D, Operations

Go-to-market motion1 record

Distribution channels2 records

Marketing channels3 records

Core offering

eHealth Innovation operates the Centre for Digital Therapeutics, based inside Toronto General Hospital (part of University Health Network). It develops a portfolio of digital therapeutic apps — Medly, iCanCope with Pain, Breathe, Ned, and bant — that transform smartphones and smartwatches into daily monitoring systems for patients with chronic conditions (heart failure, chronic pain, asthma, COPD, cancer survivorship, diabetes). The apps track vitals and flag concerning changes to clinical teams in real time.

Product overview

eHealth Innovation operates as the Centre for Digital Therapeutics, based inside the Toronto General Hospital. The organization offers a portfolio of five distinct digital therapeutic products addressing different chronic health conditions: Medly for heart failure management, iCanCope with Pain for youth chronic pain, Breathe for asthma/COPD, Ned for cancer survivorship, and bant for diabetes management. These products engage and empower patients through technology, enabling them to become partners in their own healthcare with tools to self-manage their conditions.

Differentiator

Problem solved

Functional benefit

Brands

• Medly: Digital therapeutic app for heart failure patients that transforms a patient's phone or watch into a daily monitoring system, tracking vitals and flagging concerning changes to clinical teams in real time.
• iCanCope with Pain
• Breathe
• Ned
• bant

Products and services

• Medly A digital therapeutic for heart failure management that transforms a patient's phone or watch into a daily monitoring system, tracking vitals and flagging concerning changes to clinical teams in real time.
• iCanCope with Pain
• Breathe
• Ned
• bant

Quantifiable outcome

• Medly transforms a patient's phone or watch into a daily monitoring system, tracking vitals and flagging concerning changes to clinical teams in real time. By making proactive care easier and more accessible, Medly helps reduce pressure on health systems while supporting better day-to-day management for patients.

Named customers5 records

Segments1 record

Ideal customer profiles2 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature5 records

Partnerships

One partnership is on record.

• University Health Network (UHN)coreStrategic or Co-development PartnerThe Centre for Digital Therapeutics is based inside the Toronto General Hospital, which is part of UHN, Canada's largest academic research hospital. This institutional embedding enables the Centre to collaborate with patient partners and clinician champions from within the healthcare system, co-developing digital therapeutics that address real therapeutic gaps in chronic illness care.

Scale indicators1 record

Recent moves4 records

Expansion highlights4 records

Direct peers

• Akili Interactive: Akili Interactive is a prescription digital therapeutics company delivering FDA-cleared cognitive therapeutics through mobile apps — comparable to eHealth Innovation as a digital therapeutics publisher with clinically validated, condition-specific mobile products.
• Livongo (Teladoc Health): Livongo built a digital health platform for chronic condition management (diabetes, hypertension, behavioural health) using connected devices and real-time coaching — closely aligned with eHealth Innovation's smartphone/smartwatch-based monitoring approach for chronic disease.
• Propeller Health: Propeller Health delivers digital therapeutics and connected sensors for asthma and COPD management — the same condition area as eHealth Innovation's Breathe product, with a comparable digital platform + clinical integration model.
• Omada Health: Omada Health is a leading digital therapeutics company focused on chronic disease prevention and management (diabetes, hypertension, musculoskeletal conditions), making it a direct peer in digital chronic disease therapeutics with comparable app-based, clinician-supported care delivery.
• Biofourmis: Biofourmis provides a remote patient monitoring and digital therapeutics platform for chronic and post-acute conditions (heart failure, oncology, respiratory), closely paralleling eHealth Innovation's portfolio of chronic-disease digital therapeutics with real-time clinical flagging.
• Click Therapeutics: Click Therapeutics develops prescription digital therapeutics across multiple chronic and behavioural conditions — directly comparable to eHealth Innovation's multi-condition portfolio of clinically validated digital therapeutics.
• Virta Health: Virta Health provides digitally delivered chronic disease management, most notably for type 2 diabetes — directly comparable to eHealth Innovation's bant diabetes digital therapeutic in approach and condition focus.
• WellDoc: WellDoc develops digital therapeutic platforms for chronic disease management (notably BlueStar for diabetes), making it a direct peer in clinically validated, app-based chronic disease therapeutics.

Emerging players

• Huma Therapeutics: Huma Therapeutics provides a digital health platform combining remote patient monitoring and digital biomarkers for chronic conditions, with hospital partnerships similar in spirit to eHealth Innovation's UHN-embedded model.

Regional players

• University of Toronto / UHN-affiliated digital health spinouts: Other hospital-embedded digital health research initiatives and spinouts from Canadian academic medical centres operate under similar institutional embedding and chronic disease digital therapeutic models in the Toronto/Ontario healthcare ecosystem.

Market position

Strengths4 records

Weaknesses5 records

Competitive moat5 records

Key risks5 records

Key highlights5 records

Customer concentration

• Xx.com/Official_eHI

Revenue estimate

Valuation estimate

Number of profiles

Subsidiaries5 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about eHealth Innovation